StockNews.com Begins Coverage on OncoCyte (NASDAQ:OCX)Ticker Report • 21 days ago
StockNews.com assumed coverage on shares of OncoCyte (NASDAQ:OCX - Free Report) in a report released on Sunday morning. The firm issued a sell rating on the stock. OncoCyte Stock Down 1.7 % OncoCyte...
Share to Feed
StockNews.com started coverage on shares of OncoCyte (NASDAQ:OCX - Free Report) in a report issued on Sunday morning. The firm issued a sell rating on the stock.
OncoCyte Stock Performance
Shares of...
Investment analysts at StockNews.com assumed coverage on shares of OncoCyte (NASDAQ:OCX Get Free Report) in a research note issued to investors on Tuesday. The brokerage set a...
StockNews.com assumed coverage on shares of OncoCyte (NASDAQ:OCX Free Report) in a research report released on Wednesday. The firm issued a sell rating on the stock. Several other brokerages...
StockNews.com began coverage on shares of OncoCyte (NASDAQ:OCX Get Free Report) in a research report issued on Thursday. The firm set a sell rating on the stock. A number of...
StockNews.com began coverage on shares of OncoCyte (NASDAQ:OCX Free Report) in a research report released on Friday. The brokerage issued a sell rating on the stock. Several other analysts...
StockNews.com started coverage on shares of OncoCyte (NASDAQ:OCX Free Report) in a research report sent to investors on Friday morning. The firm issued a sell rating on the stock. A number of...
IRVINE, Calif., Jan. 16, 2024 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, today announced that CEO Josh Riggs will be presenting a corporate overview at...
Equities research analysts at StockNews.com started coverage on shares of OncoCyte (NASDAQ:OCX Get Free Report) in a report released on Sunday. The firm set a sell rating on the...
StockNews.com assumed coverage on shares of OncoCyte (NASDAQ:OCX Free Report) in a research report report published on Monday morning. The firm issued a sell rating on the stock. Other...